"Viral Plaque Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
| Descriptor ID |
D010948
|
| MeSH Number(s) |
E01.370.225.875.970.790 E05.200.875.970.790
|
| Concept/Terms |
Viral Plaque Assay- Viral Plaque Assay
- Assay, Viral Plaque
- Assays, Viral Plaque
- Plaque Assay, Viral
- Plaque Assays, Viral
- Viral Plaque Assays
Bacteriophage Plaque Assay- Bacteriophage Plaque Assay
- Assay, Bacteriophage Plaque
- Assays, Bacteriophage Plaque
- Bacteriophage Plaque Assays
- Plaque Assay, Bacteriophage
- Plaque Assays, Bacteriophage
|
Below are MeSH descriptors whose meaning is more general than "Viral Plaque Assay".
Below are MeSH descriptors whose meaning is more specific than "Viral Plaque Assay".
This graph shows the total number of publications written about "Viral Plaque Assay" by people in this website by year, and whether "Viral Plaque Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Viral Plaque Assay" by people in Profiles.
-
Phage-bacterium war on polymeric surfaces: can surface-anchored bacteriophages eliminate microbial infections? Biomacromolecules. 2013 May 13; 14(5):1257-61.
-
Sanitizer efficacy against murine norovirus, a surrogate for human norovirus, on stainless steel surfaces when using three application methods. Appl Environ Microbiol. 2013 Feb; 79(4):1368-77.
-
Efficacy of a levulinic acid plus sodium dodecyl sulfate-based sanitizer on inactivation of human norovirus surrogates. J Food Prot. 2012 Aug; 75(8):1532-5.
-
The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts. J Virol. 2009 Jan; 83(2):498-511.
-
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J Virol. 2000 Apr; 74(8):3682-95.
-
Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis. J Virol. 2000 Mar; 74(5):2393-405.
-
The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. J Virol. 1995 Dec; 69(12):7823-34.
-
Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome. J Virol. 1991 Sep; 65(9):4609-18.
-
Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity. J Virol. 1991 Feb; 65(2):869-79.
-
Depression by Fc gamma receptor ligands of SRBC-induced IgM-PFC generation in human blood mononuclear cell cultures. Diagn Clin Immunol. 1988; 5(6):304-8.